|
Volumn 72, Issue 1, 2004, Pages 75-77
|
Program to improve cognitive functioning in patients with schizophrenia: Reflections
|
Author keywords
Clinical trials; Cognition; Drug discovery; Drug interaction; Genetics; Schizophrenia
|
Indexed keywords
ARIPIPRAZOLE;
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;
NOOTROPIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
ZETIDOLINE;
ZIPRASIDONE;
BRAIN FUNCTION;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFERENCE PAPER;
DRUG MEGADOSE;
DRUG RECEPTOR BINDING;
FOOD AND DRUG ADMINISTRATION;
GENOTYPE;
HUMAN;
MENTAL PATIENT;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ANTIPSYCHOTIC AGENTS;
CLINICAL TRIALS;
COGNITION DISORDERS;
CONSENSUS;
HUMANS;
PROGRAM DEVELOPMENT;
SCHIZOPHRENIA;
|
EID: 7544243444
PISSN: 09209964
EISSN: None
Source Type: Journal
DOI: 10.1016/j.schres.2004.09.005 Document Type: Conference Paper |
Times cited : (7)
|
References (3)
|